An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan Mcdermid
Tag: WW Grainger Inc
Ozempic effect has hurt a weight loss stock that’s still a top pick
Game-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived on the
Corporate profit reports next week could signal ‘earnings recession’
Investors in the week ahead will focus on how much inflation and the slowing economy have chiseled away at corporate profits, as
No More Posts Available.
No more pages to load.